Medical debt is associated with population health and increased mortality

GSK will cap out-of-pock­et costs for its in­halers at $35, mak­ing it the third ma­jor drug­mak­er to agree to lim­it pa­tients’ spend­ing amid sig­nif­i­cant US

A bi­par­ti­san group of US sen­a­tors has re­leased a con­gres­sion­al call to the pub­lic for ideas and pol­i­cy so­lu­tions on how to im­prove the 340B